{"protocolSection":{"identificationModule":{"nctId":"NCT04122599","orgStudyIdInfo":{"id":"752/2018BO2"},"organization":{"fullName":"University Hospital Tuebingen","class":"OTHER"},"briefTitle":"Melatonin for Prevention of Post Stroke Delirium","officialTitle":"Melatonin for Prevention of Post Stroke Delirium"},"statusModule":{"statusVerifiedDate":"2018-10","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2017-07-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-11-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2019-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2019-05-29","studyFirstSubmitQcDate":"2019-10-09","studyFirstPostDateStruct":{"date":"2019-10-10","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-10-09","lastUpdatePostDateStruct":{"date":"2019-10-10","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"University Hospital Tuebingen","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Post stroke delirium is prevalent in 10-30% of all stroke patients. We aimed to investigate wether Melatonin 2mg may prevent post stroke delirium."},"conditionsModule":{"conditions":["Post Stroke Delirium"],"keywords":["Melatonin"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2","PHASE3"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":2000,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Melatonin versus standard care","type":"OTHER","description":"Melatonin is tested versus standard care","interventionNames":["Drug: Melatonin"]}],"interventions":[{"type":"DRUG","name":"Melatonin","description":"Melatonin for prevent post stroke delirium","armGroupLabels":["Melatonin versus standard care"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change of delir prevalence","timeFrame":"3months"}],"secondaryOutcomes":[{"measure":"Change of hospital stay","timeFrame":"3months"},{"measure":"Change of antipsychotic drug administration","timeFrame":"3 months"},{"measure":"Changed stay on stroke unit and/or intermediate care","timeFrame":"3 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* all patients with stroke, TIA or ICH admitted to our stroke unit or intemdiate care unit\n* Stroke / ICH /TIA onset \\<= 48h\n\nExclusion Criteria:\n\n* RASS \\<=4\n* severe dementia, psychosis or depression","healthyVolunteers":false,"sex":"ALL","minimumAge":"55 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Annerose Mengel, MD","role":"CONTACT","phone":"004970712985354","email":"annerose.mengel@med.uni-tuebingen.de"}],"locations":[{"facility":"Klinik für Neurologie","status":"RECRUITING","city":"Tübingen","state":"BW","zip":"72076","country":"Germany","contacts":[{"name":"Annerose Mengel, MD","role":"CONTACT","email":"annerose.mengle@med.uni-tuebingen.de"},{"name":"Christian Bosselmann, MD","role":"CONTACT"}],"geoPoint":{"lat":48.52266,"lon":9.05222}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000003693","term":"Delirium"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000003221","term":"Confusion"},{"id":"D000019954","term":"Neurobehavioral Manifestations"},{"id":"D000009461","term":"Neurologic Manifestations"},{"id":"D000019965","term":"Neurocognitive Disorders"},{"id":"D000001523","term":"Mental Disorders"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M6584","name":"Delirium","asFound":"Delirium","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M6136","name":"Confusion","relevance":"LOW"},{"id":"M21516","name":"Neurobehavioral Manifestations","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"},{"id":"M21526","name":"Neurocognitive Disorders","relevance":"LOW"},{"id":"M4505","name":"Mental Disorders","relevance":"LOW"},{"id":"M14163","name":"Psychotic Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"}]},"interventionBrowseModule":{"meshes":[{"id":"D000008550","term":"Melatonin"}],"ancestors":[{"id":"D000000975","term":"Antioxidants"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000020011","term":"Protective Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000002492","term":"Central Nervous System Depressants"}],"browseLeaves":[{"id":"M11223","name":"Melatonin","asFound":"Ketamine","relevance":"HIGH"},{"id":"M3982","name":"Antioxidants","relevance":"LOW"},{"id":"M21559","name":"Protective Agents","relevance":"LOW"},{"id":"T410","name":"Melatonin","asFound":"Ketamine","relevance":"HIGH"}],"browseBranches":[{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Ot","name":"Other Dietary Supplements"}]}},"hasResults":false}